SKLB-03220

CAT: 0804-HY-177497Size: 1 EachDry Ice: NoHazardous: No
CAT#:0804-HY-177497Size:1 Each
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
SKLB-03220 is a selective and orally active EZH2 covalent inhibitor with an IC50 of 1.72 nM for EZH2MUT. SKLB-03220 exhibits weak activities against other tested histone methyltransferases (HMTs) and kinases. SKLB-03220 displays noteworthy potency against ovarian cancer cell lines and induces cell apoptosis. SKLB-03220 significantly inhibits tumor growth in PA-1 xenograft model. SKLB-03220 can be used for the study of ovarian cancer[1].
CAS Number
[2852050-29-2]
UNSPSC
12352005
Target
Apoptosis; Histone Methyltransferase
Related Pathways
Apoptosis; Epigenetics
Field of Research
Cancer
Smiles
O=C(NC1=CC=C(C)C(C2=CC(N(C3CCOCC3)CC)=C(C)C(C(NCC4=C(C)C=C(C)NC4=O)=O)=C2)=C1)C=C
Molecular Formula
C33H40N4O4
Molecular Weight
556.70
References & Citations
[1]Zhang Q, et al. Discovery of a Novel Covalent EZH2 Inhibitor Based on Tazemetostat Scaffold for the Treatment of Ovarian Cancer. J Med Chem. 2023 Feb 9;66 (3) :1725-1741.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
EZH2

Related Products

CatalogName
HY-18947-01SKLB-23bb
HY-178114SKLB-0124
HY-176848-01SKLB-Y13
HY-173572-01SKLB-11A
HY-120429-01SKLB-163
HY-122860SKLB-C05
HY-144217-01SKLB-197
HY-178102SKLB-0266
HY-173119-01SKLB-D18

Alternative Products

CatalogName
T207811-01SKLB-03220
M10442-01SKLB 610
M27829-01SKLB-163
MBS3842805-01SKLB-23bb
T34656-01SKLB 1028
TRC-S555010-250MGSKLB-1028
T206864-01SKLB-D18
MBS5804978SKLB-197
T210843-01SKLB-11A

Popular Products